The Working Capital Position For investors, the strength

New Post Public Reply Private Reply Replies (0) Message Board
NITE

The Working Capital Position
For investors, the strength of a company's balance sheet can be evaluated by examining three broad categories of investment quality: working capital adequacy, asset performance and capitalization structure. In this article, we'll start with a comprehensive look at how best to evaluate the investment quality of a company's working capital position. In simple terms, this entails measuring the liquidityand managerial efficiency related to a company's current position. The analytical tool employed to accomplish this task will be a company's cash conversion cycle.

SEE: Working Capital Works

Don't Be Misled by Faulty Analysis
To start this discussion, let's first correct some commonly held, but erroneous, views on a company's current position, which simply consists of the relationship between its current assets and its current liabilities. Working capital is the difference between these two broad categories of financial figures and is expressed as an absolute dollar amount.

Despite conventional wisdom, as a stand-alone number, a company's current position has little or no relevance to an assessment of its liquidity. Nevertheless, this number is prominently reported in corporate financial communications such as the annual report and also by investment research services. Whatever its size, the amount of working capital sheds very little light on the quality of a company's liquidity position.
Another piece of conventional wisdom that needs correcting is the use of the current ratio and, its close relative, the acid test or quick ratio. Contrary to popular perception, these analytical tools don't convey the evaluative information about a company's liquidity that an investor needs to know. The ubiquitous current ratio, as an indicator of liquidity, is seriously flawed because it's conceptually based on a company's liquidation of all its current assets to meet all of its current liabilities. In reality, this is not likely to occur. Investors have to look at a company as a going concern. It's the time it takes to convert a company's working capital assets into cash to pay its current obligations that is the key to its liquidity. In a word, the current ratio is misleading.

SEE: Do Your Investments Have Short-Term Health?

A simplistic, but accurate, comparison of two companies' current positions will illustrate the weakness in relying on the current ratio and a working capital number as liquidity indicators:
Liquidity Measures Company ABC Company XYZ
Current Assets $600 $300
Current Liabilities $300 $300
Working Capital $300 $0
Current Ratio 2:1 1:1

At first glance, company ABC looks like an easy winner in a liquidity contest. It has an ample margin of current assets over current liabilities, a seemingly good current ratio and a working capital of $300. Company XYZ has no current asset/liability margin of safety, a weak current ratio and no working capital.

However, what if both companies' current liabilities have an average payment period of 30 days? Company ABC needs six months (180 days) to collect its account receivables, and its inventory turns over just once a year (365 days). Company XYZ's customers pay in cash, and its inventory turns over 24 times a year (every 15 days). In this contrived example, company ABC is very illiquid and would not be able to operate under the conditions described. Its bills are coming due faster than its generation of cash. You can't pay bills with working capital; you pay bills with cash! Company XYZ's seemingly tight current position is much more liquid because of its quicker cash conversion.
Measuring a Company's Liquidity the Right Way
The cash conversion cycle (also referred to as CCC or the operating cycle) is the analytical tool of choice for determining the investment quality of two critical assets - inventory and accounts receivable. The CCC tells us the time (number of days) it takes to convert these two important assets into cash. A fast turnover rate of these assets is what creates real liquidity and is a positive indication of the quality and the efficient management of inventory and receivables. By tracking the historical record (five to 10 years) of a company's CCC and comparing it to competitor companies in the same industry (CCCs will vary according to the type of product and customer base), we are provided with an insightful indicator of a balance sheet's investment quality.

SEE: Understanding The Cash Conversion Cycle

Briefly stated, the cash conversion cycle is comprised of three standards: the so-called activity ratios relating to the turnover of inventory, trade receivables and trade payables. These components of the CCC can be expressed as a number of times per year or as a number of days. Using the latter indicator provides a more literal and coherent time measurement that is easily understood. The cash conversion cycle formula looks like this:
Days Inventory Outstanding (DIO) + Days Sales Outstanding (DSO) – Days Payable Outstanding (DPO) = CCC

Here's how the components are calculated:

• Dividing average inventories by cost of sales per day (cost of sales/365) = days inventory outstanding (DIO).

• Dividing average accounts receivables by net sales per day (net sales/365) = days sales outstanding (DSO).

• Dividing average accounts payables by cost of sales per day (cost of sales/365) = days payables outstanding (DPO).

Liquidity Is King
One collateral observation is worth mentioning here. Investors should be alert to spotting liquidity enhancers in a company's financial information. For example, for a company that has non-current investment securities, there is typically a secondary market for the relatively quick conversion of all or a high portion of these items to cash. Also, unused committed lines of credit - usually mentioned in anote to the financials on debt or in the management discussion and analysis section of a company's annual report - can provide quick access to cash.
SEE: Understanding Financial Liquidity

The Bottom Line
The old adage that "cash is king" is as important for investors evaluating a company's investment qualities as it is for the managers running the business. A liquidity squeeze is worse than a profit squeeze. A key management function is to make sure that a company's receivables and inventory positions are managed efficiently. This means ensuring an adequate level of product availability and providing appropriate payment terms, while at the same time making sure that working capital assets don't tie up undue amounts of cash. This is a balancing act for managers, but an important one. It is important because with high liquidity, a company can take advantage of price discounts on cash purchases, reduce short-term borrowings, benefit from a top commercial credit rating and take advantage of market opportunities.

The cash conversion cycle and its component parts are useful indicators of a company's true liquidity. In addition, the performance of DIO and DSO is a good indicator of management's ability to handle the important inventory and receivable assets.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 3

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

Updated Category News Views 4

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Continue Reading
Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 5

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 2

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
York Space Systems Faces Class Action Headwinds

Updated Category News Views 4

York Space Systems: Under Legal Fire You ever hear the one about York Space Systems? Yeah, their ticker YSS is buzzing for all the wrong reasons. Not even a year out from their IPO, and already they're tangled in a class action lawsuit that's got investors with their heads in their hands. ClaimsFiler, a shareholder information outfit, just blasted out a reminder for...

Continue Reading
ToolDance X1 CNC Mill Unveils at IFA 2026

Updated Category News Views 1

IFA 2026 Reveals a Game Changer: ToolDance X1 Listen up, because ToolDance just threw a curveball into the CNC world with the launch of their X1 Smart Desktop CNC Mill at the IFA 2026 in Berlin. This isn't just another gadget—it's a real player aiming to bring manufacturing muscle right to your desktop. Will Wang, the genius behind ToolDance, wants to democratize CNC...

Continue Reading
Consumer365 Lauds Happy Head's Custom Hair Treatments

Updated Category News Views 6

Revolutionizing Hair Loss Treatment The world of hair growth solutions is transforming right before our eyes. Thanks to the folks over at Happy Head and their customizable, dermatologist-prescribed treatments, the days of one-size-fits-all are ending. Consumer365 recently took a dive into Happy Head's model, giving their nod of approval to its personalized approach....

Continue Reading
Why Buyers Are Flocking to Whidbey Island Homes

Updated Category News Views 0

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Continue Reading
Tuya Presents Doova: A Senior-Friendly AI Robot

Updated Category News Views 3

IFA Unveils a Game-Changer for Senior Living Imagine having a helper at home that not only looks out for your safety but also keeps you company. That's exactly what Tuya Smart's new AI creation, Doova, is set to do. Unveiled at the IFA 2026, Doova isn't just another gadget—it’s a big leap for folks choosing to live out their golden years independently. Navigating...

Continue Reading
LiberNovo Spotlights Ergonomic Seating at Berlin's IFA 2026

Updated Category News Views 0

LiberNovo Sets the Stage at IFA 2026 If you're poking around Berlin this September, the Messe Berlin is the place to be, especially for those keeping tabs on the consumer tech world. LiberNovo, the ergonomic seating company you might not have had on your radar, is out here making noise. They're throwing down the gauntlet with the Maxis Series, promising a better deal for...

Continue Reading

Top 5 Most Recently Viewed Articles

Celsius Holdings Faces Legal Challenges—What Investors Should Know

Updated Category News Views 365

Understanding the Recent Class Action Lawsuit Against Celsius Holdings Recently, Celsius Holdings, Inc. (NASDAQ: CELH) has found itself at the center of a significant legal challenge. This class action lawsuit, filed by a prominent law firm, seeks to address serious allegations involving the company's financial disclosures and dealings with PepsiCo, Inc. The Accusations...

Continue Reading
Five Star Bancorp Announces Next Cash Dividend for Shareholders

Updated Category News Views 138

Five Star Bancorp's Dividend Announcement Five Star Bancorp (Nasdaq: FSBC) is pleased to share exciting news regarding its latest shareholder return strategy. The company has declared a cash dividend amounting to $0.20 per share on its voting common stock. This marks a continuing commitment to delivering value to its shareholders and is a pivotal part of the firm’s...

Continue Reading
Enovix Shares Decline as Q3 Report Shifts Market Sentiment

Updated Category News Views 151

Enovix Experiences Stock Decline Post Q3 Report Enovix Corporation (NASDAQ: ENVX) is facing a significant drop in its stock price as investors react to its recent third-quarter financial results. The company reported quarterly losses and provided guidance for the upcoming quarter that did not meet market expectations, leading to a decline in share value. Details of the...

Continue Reading
Borregaard ASA Launches Strategic Share Repurchase Program

Updated Category News Views 129

Borregaard ASA Announces Share Repurchase Initiative Borregaard ASA, known by the ticker OSE: BRG, is set to execute a strategic share repurchase program aiming to enhance shareholder value. This initiative involves the buyback of up to 200,000 shares of the company’s outstanding common stock. Purpose of the Share Repurchase Program The primary goal of this repurchase...

Continue Reading
Forian Expands Influence with Acquisition of Kyber Data Science

Updated Category News Views 103

Forian's Strategic Move to Acquire Kyber Data Science Forian Inc. (Nasdaq: FORA), a prominent data science company, is making headlines with its recent acquisition of Kyber Data Science LLC. This move is set to enhance Forian's capabilities in the healthcare analytics arena while also enabling the company to expand into the financial services sector. Kyber Data Science: A...

Continue Reading